查看購物車
  • Simplified Chinese
  • English
2021-2031年北美類器官市場報告：範圍、細分、動態和競爭分析
市場調查報告書
商品編碼
1871517

2021-2031年北美類器官市場報告：範圍、細分、動態和競爭分析

North America Organoids Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 197 Pages | 訂單完成後即時交付

價格

預計北美類器官市場將大幅成長，到 2031 年將達到約 65.7444 億美元，高於 2023 年的 13.5719 億美元，2023 年至 2031 年的年複合成長率(CAGR) 為 21.8%。

執行摘要和市場分析

北美類器官市場主要分為三大區域：美國、加拿大和墨西哥。截至2023年，美國在該市場佔據主導地位，這主要得益於慢性疾病和病毒感染的日益普遍、類器官模型的商業化、研發活動的增加以及幹細胞研究的進步。此外，類器官研究的資助和經費增加也進一步推動了市場成長。

市場區隔分析

北美類器官市場可以透過多種細分市場進行分析，包括類型、應用、來源、供應和方法：

  • 類型：市場依類器官來源可分為腸道、肝臟、胃、胰臟、肺、腦、腎臟等。 2023年，腸道類器官佔據最大的市場佔有率。
  • 應用領域：類器官的應用領域包括發育生物學、傳染病病理學、再生醫學、藥物毒性和療效測試、藥物研發、個人化醫療等。 2023年，發育生物學應用領域佔據市場主導地位。
  • 資料來源：市場分為源自多能幹細胞的類器官和源自器官特異性成體幹細胞的類器官，其中多能幹細胞在 2023 年將佔據更大的市場佔有率。
  • 產品/服務：此業務板塊包括儀器、耗材和服務，其中耗材在 2023 年是最大的業務板塊。儀器又分為設備和儀器，而耗材包括感測器和其他物品。
  • 方法：類器官培養方法包括微圖案化培養板、超低吸附培養板、懸滴法、微滴法或乳液法等。其中，懸滴法在2023年最為突出。

市場展望

技術進步正推動類器官與晶片器官技術的融合，從而增強其在生物學和生物醫學研究中的應用，尤其是在疾病建模和臨床藥物篩選方面。類器官與晶片器官系統的結合正在改變癌症研究範式，並帶來實際的臨床效益。類器官與晶片器官和3D生物列印技術的協同應用，使得建構先進的癌症模型成為可能，從而能夠研究腫瘤-基質相互作用、多器官腫瘤轉移以及癌症微環境動態變化。

將多個類器官整合到單一晶片上的晶片類器官系統，是一個極具潛力的新興領域。這種創新方法能夠對多器官腫瘤轉移及其在癌症微環境中的相互作用進行全面研究。近期的進展已成功建構出腦、肝、腸類器官晶片，預示該領域擁有廣闊的發展前景。

國家概況

北美類器官市場主要由美國、加拿大和墨西哥所構成，其中美國在2023年佔據最大的市場佔有率。類器官正在突破生物醫學研究的現有限制，為人類發育提供新的見解，建構精準的疾病模型，並產生用於再生醫學的患者特異性組織。哈佛大學維斯研究所和杜克大學等機構進行的傑出研究項目，已成功開發出支持卵子成熟的人類卵巢類器官，並有望用於治療不孕症和卵巢癌。這項技術已授權給Gameto公司，並正被用於開發治療女性生殖健康問題的療法。此外，辛辛那提兒童醫院幹細胞和類器官醫學中心（CuSTOM）正致力於透過創新的幹細胞技術和類器官來推廣個人化再生療法，旨在建立用於治療的患者特異性組織。

公司簡介

類器官市場的主要參與者包括 STEMCELL Technologies Inc.、Molecular Devices, LLC、Hubrecht Organoid Technology、Definigen、Organoid Therapeutics、Thermo Fisher Scientific Inc.、Corning Inc.、Merck KGaA、InSphero、ACRO Biosystems、Bio-Techne Corp.、SUNGAN SCI. AG、3D Biotek LLC、Prellis Biologics Inc.、3Dnamics Inc. 和 Cellesce Ltd.。這些公司正在採用各種策略，包括擴張、產品創新以及併購，以增強其市場佔有率並為消費者提供創新解決方案。

目錄

第1章：引言

第2章：執行概要

  • 關鍵見解

第3章：研究方法

  • 二手研究
  • 初步研究
    • 假設的提出：
    • 宏觀經濟因素分析：
    • 發展基礎數字：
    • 數據三角測量：
    • 國家層面資料：

第4章：北美類器官市場－主要市場動態

  • 市場促進因素
    • 對腫瘤建模和生物樣本庫的需求日益成長
    • 個人化藥物的廣泛應用
  • 市場限制
    • 缺乏熟練的專業人才
  • 市場機遇
    • 重點關注藥物發現活動
  • 未來趨勢
    • 類器官與晶片器官的結合
  • 駕駛員和安全帶的影響：

第5章：類器官市場－北美分析

  • 2021-2031年北美類器官市場收入
  • 北美類器官市場預測分析

第6章：北美類器官市場分析－依類型

  • 腸
  • 肝
  • 胃
  • 胰臟
  • 肺
  • 腦
  • 腎
  • 其他

第7章：北美類器官市場分析－按應用領域分類

  • 發育生物學疾病
  • 傳染病病理學
  • 再生醫學
  • 藥物毒性和療效測試
  • 藥物發現與個人化醫療
  • 其他

第8章：北美類器官市場分析－依來源分類

  • 多能幹細胞
  • 器官特異性成體幹細胞

第9章：北美類器官市場分析－依產品類型分類

  • 儀器
  • 消耗品
  • 服務

第10章：北美類器官市場分析－依方法分類

  • 微圖案板
  • 超低附件板
  • 懸垂
  • 微滴或乳液
  • 其他

第11章：北美類器官市場－國家分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥

第12章：行業概況

  • 概述
  • 類器官市場成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第13章：公司簡介

  • STEMCELL Technologies Inc
  • Molecular Devices, LLC.
  • Hubrecht Organoid Technology
  • Definigen
  • Organoid Therapeutics
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Merck KGaA
  • InSphero
  • ACRO Biosystems.
  • Bio-Techne Corp
  • SUN bioscience SA
  • ORGANOID SCIENCES Co., Ltd.
  • Crown Bioscience Inc
  • Sartorius AG
  • 3D Biotek LLC
  • Prellis Biologics Inc.
  • 3Dnamics Inc.
  • Cellesce Ltd

第14章：附錄

Product Code: TIPRE00018845

The North America organoids market is projected to grow significantly, reaching approximately USD 6,574.44 million by 2031, up from USD 1,357.19 million in 2023, reflecting a compound annual growth rate (CAGR) of 21.8% from 2023 to 2031.

Executive Summary and Market Analysis

The North America organoids market is divided into three main regions: the United States, Canada, and Mexico. As of 2023, the United States dominates the market, driven by an increasing prevalence of chronic diseases and viral infections, the commercialization of organoid models, heightened research and development activities, and advancements in stem cell research. Additionally, the rise in grants and funding for organoid research is further fueling market growth.

Market Segmentation Analysis

The North America organoids market can be analyzed through various segments, including type, application, source, offering, and method:

  • Type: The market is categorized into organoids derived from the intestine, liver, stomach, pancreas, lung, brain, kidney, and others. In 2023, intestinal organoids held the largest market share.
  • Application: The applications of organoids are segmented into developmental biology, infectious disease pathology, regenerative medicine, drug toxicity and efficacy testing, drug discovery, personalized medicine, and others. Developmental biology applications led the market in 2023.
  • Source: The market is divided into organoids sourced from pluripotent stem cells and organ-specific adult stem cells, with pluripotent stem cells holding a larger market share in 2023.
  • Offering: This segment includes instruments, consumables, and services, with consumables being the largest segment in 2023. Instruments are further divided into devices and equipment, while consumables include sensors and other items.
  • Method: The methods used in organoid development include micropatterned plates, ultralow attachment plates, hanging drop, microdroplet or emulsion techniques, and others. The hanging drop method was the most prominent in 2023.

Market Outlook

Technological advancements are paving the way for integrating organoids with organ-on-a-chip technologies, enhancing applications in biological and biomedical research, particularly in disease modeling and clinical drug screening. Organoids combined with organ-on-a-chip systems are transforming cancer research paradigms and offering tangible clinical benefits. The collaborative use of organoids with organ-on-a-chip and 3D bioprinting is enabling the creation of advanced cancer models to investigate tumor-stroma interactions, multiorgan tumor metastasis, and cancer-microenvironment dynamics.

The development of organoid-on-a-chip systems, which incorporate multiple organoids on a single chip, is an emerging area with significant potential. This innovative approach allows for comprehensive studies of multiorgan tumor metastases and interactions within the cancer microenvironment. Recent advancements have led to the creation of brain, liver, and intestinal organoids-on-chip, indicating a promising future for this segment.

Country Insights

The North American organoids market is primarily represented by the US, Canada, and Mexico, with the US holding the largest market share in 2023. Organoids are overcoming previous limitations in biomedical research, providing insights into human development, creating accurate disease models, and generating patient-specific tissues for regenerative medicine. Notable research initiatives, such as those at the Wyss Institute at Harvard University and Duke University, have led to the development of human ovarian organoids that support egg maturation, potentially aiding in treatments for infertility and ovarian cancer. This technology, licensed to Gameto, is being utilized to develop therapeutics for female reproductive health issues. Furthermore, the Center for Stem Cell and Organoid Medicine (CuSTOM) at Cincinnati Children's Hospital is advancing personalized regenerative therapies through innovative stem cell technologies and organoids, aiming to engineer patient-specific tissues for therapeutic use.

Company Profiles

Key players in the organoids market include STEMCELL Technologies Inc., Molecular Devices, LLC, Hubrecht Organoid Technology, Definigen, Organoid Therapeutics, Thermo Fisher Scientific Inc., Corning Inc., Merck KGaA, InSphero, ACRO Biosystems, Bio-Techne Corp, SUN bioscience SA, ORGANOID SCIENCES Co., Ltd., Crown Bioscience Inc., Sartorius AG, 3D Biotek LLC, Prellis Biologics Inc., 3Dnamics Inc., and Cellesce Ltd. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their market presence and deliver innovative solutions to consumers.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. North America Organoids Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Demand for Tumor Modeling and Biobanking
    • 4.1.2 Surging Adoption of Personalized Drugs
  • 4.2 Market Restraints
    • 4.2.1 Dearth of Skilled Professionals
  • 4.3 Market Opportunities
    • 4.3.1 Focus on Drug Discovery Activities
  • 4.4 Future Trends
    • 4.4.1 Combination of Organoids and Organ-on-a-Chip
  • 4.5 Impact of Drivers and Restraints:

5. Organoids Market - North America Analysis

  • 5.1 North America Organoids Market Revenue (US$ Million), 2021-2031
  • 5.2 North America Organoids Market Forecast Analysis

6. North America Organoids Market Analysis - by Type

  • 6.1 Intestine
    • 6.1.1 Overview
    • 6.1.2 Intestine: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.2 Liver
    • 6.2.1 Overview
    • 6.2.2 Liver: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.3 Stomach
    • 6.3.1 Overview
    • 6.3.2 Stomach: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.4 Pancreas
    • 6.4.1 Overview
    • 6.4.2 Pancreas: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.5 Lung
    • 6.5.1 Overview
    • 6.5.2 Lung: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.6 Brain
    • 6.6.1 Overview
    • 6.6.2 Brain: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.7 Kidney
    • 6.7.1 Overview
    • 6.7.2 Kidney: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.8 Others
    • 6.8.1 Overview
    • 6.8.2 Others: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. North America Organoids Market Analysis - by Application

  • 7.1 Developmental Biology Disease
    • 7.1.1 Overview
    • 7.1.2 Developmental Biology Disease: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Pathology of Infectious Disease
    • 7.2.1 Overview
    • 7.2.2 Pathology of Infectious Disease: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Regenerative Medicine
    • 7.3.1 Overview
    • 7.3.2 Regenerative Medicine: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Drug Toxicity and Efficacy Testing
    • 7.4.1 Overview
    • 7.4.2 Drug Toxicity and Efficacy Testing: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Drug Discovery and Personalized Medicine
    • 7.5.1 Overview
    • 7.5.2 Drug Discovery and Personalized Medicine: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Organoids Market Analysis - by Source

  • 8.1 Pluripotent Stem Cells
    • 8.1.1 Overview
    • 8.1.2 Pluripotent Stem Cells: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Organ-Specific Adult Stem Cell
    • 8.2.1 Overview
    • 8.2.2 Organ-Specific Adult Stem Cell: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Organoids Market Analysis - by Offering

  • 9.1 Instruments
    • 9.1.1 Overview
    • 9.1.2 Instruments: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Consumables
    • 9.2.1 Overview
    • 9.2.2 Consumables: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Services
    • 9.3.1 Overview
    • 9.3.2 Services: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Organoids Market Analysis - by Method

  • 10.1 Micropatterned Plates
    • 10.1.1 Overview
    • 10.1.2 Micropatterned Plates: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.2 Ultralow Attachment Plates
    • 10.2.1 Overview
    • 10.2.2 Ultralow Attachment Plates: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.3 Hanging Drop
    • 10.3.1 Overview
    • 10.3.2 Hanging Drop: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.4 Microdroplet or Emulsion
    • 10.4.1 Overview
    • 10.4.2 Microdroplet or Emulsion: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

11. North America Organoids Market - Country Analysis

  • 11.1 North America
    • 11.1.1 North America Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 North America Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.2 United States: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.1.2.1 United States: North America Organoids Market Share - by Type
        • 11.1.1.2.2 United States: North America Organoids Market Share - by Application
        • 11.1.1.2.3 United States: North America Organoids Market Share - by Source
        • 11.1.1.2.4 United States: North America Organoids Market Share - by Offering
        • 11.1.1.2.5 United States: North America Organoids Market Share - by Instruments
        • 11.1.1.2.6 United States: North America Organoids Market Share - by Consumables
        • 11.1.1.2.7 United States: North America Organoids Market Share - by Method
      • 11.1.1.3 Canada: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.1.3.1 Canada: North America Organoids Market Share - by Type
        • 11.1.1.3.2 Canada: North America Organoids Market Share - by Application
        • 11.1.1.3.3 Canada: North America Organoids Market Share - by Source
        • 11.1.1.3.4 Canada: North America Organoids Market Share - by Offering
        • 11.1.1.3.5 Canada: North America Organoids Market Share - by Instruments
        • 11.1.1.3.6 Canada: North America Organoids Market Share - by Consumables
        • 11.1.1.3.7 Canada: North America Organoids Market Share - by Method
      • 11.1.1.4 Mexico: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.1.4.1 Mexico: North America Organoids Market Share - by Type
        • 11.1.1.4.2 Mexico: North America Organoids Market Share - by Application
        • 11.1.1.4.3 Mexico: North America Organoids Market Share - by Source
        • 11.1.1.4.4 Mexico: North America Organoids Market Share - by Offering
        • 11.1.1.4.5 Mexico: North America Organoids Market Share - by Instruments
        • 11.1.1.4.6 Mexico: North America Organoids Market Share - by Consumables
        • 11.1.1.4.7 Mexico: North America Organoids Market Share - by Method

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Organoids Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 STEMCELL Technologies Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Molecular Devices, LLC.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Hubrecht Organoid Technology
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Definigen
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Organoid Therapeutics
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Thermo Fisher Scientific Inc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Corning Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Merck KGaA
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 InSphero
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 ACRO Biosystems.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Bio-Techne Corp
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 SUN bioscience SA
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 ORGANOID SCIENCES Co., Ltd.
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Crown Bioscience Inc
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Sartorius AG
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 3D Biotek LLC
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments
  • 13.17 Prellis Biologics Inc.
    • 13.17.1 Key Facts
    • 13.17.2 Business Description
    • 13.17.3 Products and Services
    • 13.17.4 Financial Overview
    • 13.17.5 SWOT Analysis
    • 13.17.6 Key Developments
  • 13.18 3Dnamics Inc.
    • 13.18.1 Key Facts
    • 13.18.2 Business Description
    • 13.18.3 Products and Services
    • 13.18.4 Financial Overview
    • 13.18.5 SWOT Analysis
    • 13.18.6 Key Developments
  • 13.19 Cellesce Ltd
    • 13.19.1 Key Facts
    • 13.19.2 Business Description
    • 13.19.3 Products and Services
    • 13.19.4 Financial Overview
    • 13.19.5 SWOT Analysis
    • 13.19.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners

List Of Tables

  • Table 1. North America Organoids Market Segmentation
  • Table 2. North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
  • Table 4. North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 5. North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source
  • Table 6. North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Offering
  • Table 7. North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Method
  • Table 8. North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 9. United States: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 10. United States: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 11. United States: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 12. United States: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 13. United States: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 14. United States: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 15. United States: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 16. Canada: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 17. Canada: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 18. Canada: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 19. Canada: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 20. Canada: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 21. Canada: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 22. Canada: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 23. Mexico: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 24. Mexico: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 25. Mexico: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 26. Mexico: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 27. Mexico: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 28. Mexico: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 29. Mexico: North America Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 30. Recent Organic Growth Strategies in Organoids Market
  • Table 31. Recent Inorganic Growth Strategies in the Organoids Market

List Of Figures

  • Figure 1. North America Organoids Market Segmentation - Country
  • Figure 2. North America Organoids Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Organoids Market Revenue (US$ Million), 2021-2031
  • Figure 5. North America Organoids Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Intestine: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Liver: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Stomach: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Pancreas: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Lung: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Brain: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Kidney: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Others: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. North America Organoids Market Share (%) - by Application (2023 and 2031)
  • Figure 15. Developmental Biology Disease: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Pathology of Infectious Disease: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Regenerative Medicine: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Drug Toxicity and Efficacy Testing: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Drug Discovery and Personalized Medicine: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Others: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. North America Organoids Market Share (%) - by Source (2023 and 2031)
  • Figure 22. Pluripotent Stem Cells: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 23. Organ-Specific Adult Stem Cell: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. North America Organoids Market Share (%) - by Offering (2023 and 2031)
  • Figure 25. Instruments: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. Consumables: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 27. Services: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 28. North America Organoids Market Share (%) - by Method (2023 and 2031)
  • Figure 29. Micropatterned Plates: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 30. Ultralow Attachment Plates: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 31. Hanging Drop: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 32. Microdroplet or Emulsion: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. Others: North America Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. North America Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 35. United States: North America Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 36. Canada: North America Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 37. Mexico: North America Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 38. Growth Strategies in Organoids Market